Interscope’s EndoRotor microdebrider system received FDA clearance for pulmonary indications. The product was previously cleared for use in gastroenterology and colorectal surgery.
The flexible debrider device is used to access distal lesions in the digestive tract. The micro-debridement reduces the need for surgery to remove necrosis and recurrent benign tumors.
The company plans to break into the pulmonary market now that the debrider device is cleared for pulmonary use.